Mitral Valve Prolapse clinical trials

Explore recruiting mitral valve prolapse clinical trials.

Recruiting mitral valve prolapse studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mitral Valve Prolapse trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Investigator-Initiated Prospective Randomized Open-Label Blinded-Endpoint Crossover Trial Comparing the Effect and Safety of Flecainide and Metoprolol versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse (FLECAPRO).

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mitral Valve Prolapse trials by city

Mitral Valve Prolapse in Toronto Mitral Valve Prolapse in Vancouver Mitral Valve Prolapse in Montreal Mitral Valve Prolapse in Calgary Mitral Valve Prolapse in Edmonton Mitral Valve Prolapse in Ottawa Mitral Valve Prolapse in Winnipeg Mitral Valve Prolapse in Quebec City Mitral Valve Prolapse in Hamilton Mitral Valve Prolapse in Kitchener Mitral Valve Prolapse in London Mitral Valve Prolapse in Halifax Mitral Valve Prolapse in New York Mitral Valve Prolapse in Los Angeles Mitral Valve Prolapse in Chicago Mitral Valve Prolapse in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease